About Personalis
Personalis is a company based in Menlo Park (United States) founded in 2011. Personalis has raised $87.3 million across 5 funding rounds from investors including Merck, Lightspeed Venture Partners and Leland Stanford Junior University. The company has 229 employees as of December 31, 2024. Personalis operates in a competitive market with competitors including MedGenome, Foundation Medicine, Tempus, Veritas Genetics and CancerIQ, among others.
- Headquarter Menlo Park, United States
- Employees 229 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Personalis, Inc.
-
Annual Revenue
$84.61 M (USD)15.15as on Dec 31, 2024
-
Net Profit
-$81.28 M (USD)24.94as on Dec 31, 2024
-
EBITDA
-$57.33 M (USD)32.56as on Dec 31, 2024
-
Total Equity Funding
$87.3 M (USD)
in 5 rounds
-
Latest Funding Round
$50 M (USD), Post-IPO
Dec 19, 2024
-
Investors
Merck
& 5 more
-
Employee Count
229
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Personalis
Personalis is a publicly listed company on the NASDAQ with ticker symbol PSNL in USA, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
People of Personalis
Unlock access to complete
Unlock access to complete
Funding Insights of Personalis
Personalis has successfully raised a total of $87.3M across 5 strategic funding rounds. The most recent funding activity was a Post-IPO round of $50 million completed in December 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Personalis
Personalis has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Merck, Lightspeed Venture Partners and Leland Stanford Junior University.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investing in innovative companies across global sectors is undertaken by Lightspeed Venture Partners.
|
Locked | Locked | Locked | |
|
Venture capital investments are managed in technology and healthcare sectors by this firm.
|
Locked | Locked | Locked | |
|
Early stage venture capital firm investing in US
|
Locked | Locked | Locked |
Investor details for Personalis
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Personalis
Investment portfolio details for Personalis
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Personalis
Detailed financials for Personalis
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Personalis Comparisons
Peer comparison for Personalis
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Personalis
Personalis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MedGenome, Foundation Medicine, Tempus, Veritas Genetics and CancerIQ, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
DNA sequencing, bioinformatics, and multiomics services are provided.
|
|
| Locked | Locked | Locked |
Genomics-based diagnostic tests for cancer are provided.
|
|
| Locked | Locked | Locked |
AI-based precision medicine solutions for oncology are provided.
|
|
| Locked | Locked | Locked |
Genetic testing products for health risks and traits are offered.
|
|
| Locked | Locked | Locked |
CancerIQ is focused on precision cancer prevention and care.
|
Detailed competitors of Personalis
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Personalis
Complete news archive for Personalis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Personalis
Personalis was founded in 2011.
Personalis is headquartered in Menlo Park, United States. It is registered at Menlo Park, California, United States.
Personalis is a funded company, having raised a total of $87.3M across 5 funding rounds to date.
As of Dec 31, 2024, the latest employee count at Personalis is 229.
Annual revenue of Personalis is $84.61M as on Dec 31, 2024.
Personalis was founded in 2011 and is headquartered in Menlo Park, United States. Services in the healthcare sector focus on genomic sequencing of DNA, RNA, augmented exome, and targeted transcriptome. Products such as the ImmunoID NeXT platform support precision oncology through analytical algorithms for immune checkpoints and related information. Additional offerings include RepertoireID for tumor sample analysis, ImmunogenomicsID, and NeoantigenID.
Personalis's top competitors include Tempus, Foundation Medicine and MedGenome.
Yes, Personalis is publicly traded on NASDAQ under the ticker symbol PSNL.
Personalis has 6 investors. Key investors include Merck, Lightspeed Venture Partners, Leland Stanford Junior University, Abingworth, and Mohr Davidow Ventures.
The ticker symbol of Personalis is PSNL on NASDAQ.